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Abstract: Previous research has identified that neurocognition predicts functional outcome in 
schizophrenia to a greater extent than psychopthology. More contemporary authors have 
begun to explore the role of metacognition as a mediating variable between neurocognition 
and functional outcome. The present review sought to extend the known work by 
synthesising the results reported in individual studies to see if these results are consistently 
found across samples. Relevant search strategies were entered into Medline (PubMed), 
PsychINFO and Embase. The present meta-analysis encompassed 17 studies (N=1060) 
investigating the relationship between neurocognition and metacognition and 7 studies 
investigating the relationship between metacognition and functional outcome (N=645). A 
small-to-moderate mean effect size was found between neurocognition and metacognition  
(effect size range .13 -.58,) and a small-to-moderate effect size was found between 
metacognition and functional outcome (range .17 - .57). Study findings suggest that 
relationships between variables are consistently found across samples and that future research 
should focus on investigating this relationship at earlier stages of illness, in female cohorts 
and across cognitive domains. Greater investigation is required in functional outcome, 
differentiating the impact of metacognition on functional capacity and other domains of 
functional outcome. 
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Introduction 
Cognitive impairment in schizophrenia is a core deficit of the disorder (Heinrichs & Zakzanis, 
1998) and observed across prodromal (Jahshan et al., 2010), first-episode (Mesholam-Gately et al., 
2009) and into remission stages (Hoff et al., 2005) Whilst cognitive deterioration has generally not 
been found to be progressive in first-episode psychosis (FEP) (Leeson et al., 2011), improvements 
after illness remain diminutive in certain domains such as IQ, working memory and processing 
speed (González-Ortega et al., 2012). Cognitive performance has also been implicated in 
predicting functional status in people with schizophrenia (Tolman & Kurtz, 2010) and found to 
be a better determinant of outcome than psychopathology (Green, 1996). Green, Kern and Heaton  
(2004) in a review, report cognitive impairment to explain between 20-60% of variance in outcome 
with Couture, Penn, and Roberts (2006), in further review positing that studies exceeding 40% of 
variance were very much the exception. 
 
The relationship identified between cognitive ability and community function led to the 
development of cognitive remediation programmes with the aim of improving the cognitive skills 
possessed by those with a diagnosis of schizophrenia to improve their community functioning. 
Despite some gains in function from remediation initiative (Wykes et al., 2007), not all of the skills 
necessarily translated into real-world improvements (Wykes et al., 2012) and led researchers to 
look for mediating variables to account for this relationship. Studies have suggested social 
cognition (Addington, Saeedi & Addington, 2006), social discomfort (Bell et al., 2009), defeatist 
beliefs (Grant & Beck, 2009), intrinsic motivation (Nakagami et al., 2008) and negative symptoms 
(Couture, Granholm & Fish, 2011) as potential mediating variables between neurocognition and 
outcome. Proposed variables however have not yet provided conclusive results and much of the 
relationship between neurocognition and functional outcome still remains unaccounted for (Fett 
et al., 2011). One approach has been to implicate metacognition in this model (Lysaker et al., 
2010a) and research has begun to explore the relationship between neurocognition and 
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metacognition. By improving an individual’s metacognitive abilities, the cognitive skill 
improvements can potentially be integrated into social and occupational situations (Lysaker et al., 
2010a). 
Metacognition refers to the cognitive processes involved in thinking about thinking (Flavell, 1979) 
and incorporates how we monitor and control, slave cognitive mechanisms (Frith, 2012). Most 
models of metacognition propose a multi-level hierarchical system, with a higher order theory and 
knowledge based (Koriat & Levy-Sadot, 1999), meta-level processing (Nelson & Narens, 1994) 
comprising of explicit, effortful processing (Frith, 2012) and the synthesis of complex information 
to compile a representation of one’s own cognitive world (Lysaker et al., 2008). This higher-order 
metacognitive knowledge interacts with lower-order subjective experience-based (Koriat & Levy-
Sadot, 1999), automatic, implicit (Frith, 2012) metacognitive judgements to regulate object-level 
processing units. Metacognition involves the ability to have an awareness of and monitor one’s 
own mental states, consider the fallibility of cognitive products and be able to form, revise and so 
control one’s mental states in rapidly evolving contexts (Lysaker et al., 2010b). Thus metacognition 
potentially draws upon memory, working memory and executive monitoring and control 
processes. 
An inability to integrate ideas about oneself and others may lead to misinterpretation of social 
situations and avoidance of participating in them (Lysaker et al., 2011a). The inability to consider 
the bigger picture and one’s role in it may lead to the poor identification and solving of social and 
psychological problems (Lysaker et al., 2011b). Thus a deficit in the ability to access metacognitive 
knowledge may leave individuals with basic evolutionary responses such as fight-or-flight to 
respond to challenges and frequent employment of anxious arousal and hyper-vigilance (Gilbert, 
2001). The ability to produce an accurate representation of one’s cognition and to reflect back on 
it will lead to improved control over cognition and better application of neurocognition to the real 
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world (Lysaker et al., 2011a). Thus improved metacognitive knowledge will lead to improved 
functional outcome in the community. 
Whilst neurocognitive deficits have proven links to impoverished psychosocial function (Green et 
al., 2000), metacognition may offer an explanation in addition to neurocognition. Despite being 
considered relatively trait-like in schizophrenia (Lysaker et al., 2014), metacognitive capacity is 
impacted by situational, cognitive and emotional demands (Dimaggo et al., 2009) and may 
therefore impact differently on capacity to complete daily tasks and actual real-world functioning.  
Previous studies have included varying measures of both metacognition and functional outcome 
each with differing design problems. Functional capacity is the ability to successfully simulate 
everyday tasks under observation from a researcher. Capacity measures only assess the ability to 
conduct a task but not whether these are employed in real-life (McKibbin et al., 2004) and self-
report measures of outcome are victim to bias and level of insight (Atkinson, Zibin & Chuang, 
1997). Likewise, studies have often employed individual measures of metacognition (see table 1) 
and investigating whether these relationships to functional outcome are observed across 
metacognitive domains would therefore be valuable to understand. 
Study aims 
The primary goals of this review will therefore be to a) identify the patterns across studies for the 
relationship between neurocognition and metacognition, and b) to assess the overall relationship 
between metacognition and functional outcome across studies, through a meta-analytic technique. 
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Method 
Studies investigating the relationship between neurocognition and metacognition were identified 
through a computerised search of the electronic databases Medline (PubMed), PsychINFO and 
Embase incorporating publications from the years 1983-2016. The syntax (schiz$ OR psychosis) 
AND (cogn$ or neurocogn$) AND (metacogn$) was included in the search strategy. The term 
metacogn$ was decided upon due to the ambiguity in definition across research disciplines and the 
potential for the term metacognition to serve as an umbrella term for a host of processing avenues. 
The present review as an exploratory paper adopted this more rigid definition to ensure clarity in 
inclusion criteria. Studies investigating the relationship between metacognition and functional 
outcome were also identified through a second computerised search with the syntax (schiz$ OR 
psychosis) AND (metacogn$) AND (function$). A secondary search of the grey literature to find 
unpublished data and PhD dissertations was completed with no additional papers found. Duplicate 
articles were removed, articles not written in English, editorials, study protocols, non-human 
populations, articles published solely in abstract form and conference proceedings and dissertation 
articles were also removed. Review articles and meta-analyses were excluded however the reference 
lists were systematically explored to ensure that any further articles missed in the original search 
strategy were included in the review. The retrieved studies’ abstract and reference sections were 
hand-screened for additional citations.  
Articles employing the metacognition assessment scale (MAS) and the Beck cognitive insight scale 
(BCIS), were grouped together as measures of metacognition. Self-reported measures of function 
have been shown to be victim to confounding factors such as insight, depression (McKibbin et al., 
(2004) and psychopathology (Atkinson, Zabin & Chuang, 1997) therefore only clinician-rated and 
objective measures of function were included in the overall analysis. 
To assess how specific cognitive domains relate to metacognition, a secondary analysis was 
conducted exploring how memory, executive function and verbal IQ relate to metacognition 
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individually. This may rule out one domain driving the relationship rather than neurocognition 
generally.
Statistical analysis 
The observed correlations from each study were subjected to Fisher’s r-to-z transformations as 
advised by Hedges and Olkin (1985). The z-transformed correlations were then weighted by their 
inverse standard error. The sum of weights and sum of weighted effect sizes were calculated to 
produce the weighted mean effect size and heterogeneity was investigated using the Q and I2 
statistic. Q statistics were then compared to critical values to ensure no violations of homogeneity. 
Confidence intervals were calculated for all studies in addition to mean effect sizes. A random 
effects model was employed (Hedges & Olkin, 1985) and results (Zr ) were transformed back to 
the r-metric prior to reporting. 
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Results 
The relationship between neurocognition and metacognition 
 
[Insert table 1 here] 
 
The literature search identified 17 final papers that reported a relationship between neurocognition 
and metacognition. Based on findings from Lysaker et al (2013),  who found that the MAS and 
BCIS measures loaded on the same component in a Principle Component Analysis (PCA), these 
variables were combined in the current paper, when considering the relationship between 
metacognition and both neurocognition and functional outcome. Neurocognition was measures 
by the WCST in six studies, the WAIS vocabulary scale in four studies, a neurocognition composite 
score in 3 and the DKEFS sorting task, HVLT, NART and WMS in one study each. Metacognition 
was measured with the MAS in 12 studies, the BCIS in four and a combined factor of both in one 
final study. 
The papers all included adult schizophrenia samples except for one FEP paper, with the majority 
using a DSM-IV diagnostic criteria. The mean age of participants included in the review was 42.35 
(range 23.2-50.5). 
[Insert figure 1 here] 
Metacognition measurement 
Metacognition was measured through two methods in the papers included. The MAS uses the 
Indiana Psychiatric Illness Interview (IPII), a semi-structured interview designed to explore 
narratives of both the self and illness in those with schizophrenia. The interview is designed to be 
conversational and participants are required to generate a personal narrative and self-reflect which 
can be analysed in terms of metacognitive capacity. The scale is comprised of 4 subscales; 
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understanding one’s own mind or self-reflectivity, understanding others’ mind, mastery and decentration. A higher 
score translates to better metacognitive ability (see Lysaker et al., 2007) for validity and reliability 
information). The MAS appears to assess synthetic forms of metacognitive processing which are 
effortful, deliberate, naturally occurring within a personal narrative. 
The Beck Cognitive Insight Scale (BCIS) is a 15-item questionnaire assessing how participants 
assess their own judgements. The measure contains two subscales; self-reflectivity and self-certainty 
relating to the ability to reflect back on cognition and confidence in cognitive products. An overall 
score of cognitive insight or composite index score is obtained by subtracting the self-certainty score 
from the self-reflectivity score (see Beck et al., (2004) for scale validation). The BCIS is a general 
reflection upon one’s thinking and is not context specific.  
 
Neurocognition and metacognition 
An initial analysis was run to investigate the relationship between neurocognition and 
metacognition. Only one effect size from each paper was included to prevent the sample 
population being included twice. In the situation where two cognitive tasks were available from 
the same cognitive domain for a paper, the most commonly reported measure’s effect size was 
selected to match other papers in the analysis. 
[Insert figure 2 here]  
Effect sizes were extracted from 17 papers. Effect sizes for the relationship ranged from -.25 -.58 
and a total of 1060 participants were pooled. The Q statistic was non-significant (Q=16.45, df=16, 
p>.05) and I2= 0.03 suggesting homogeneity of variance. The Z statistic suggested a significant 
relationship between neurocognition and metacognition (Z= 6.43, p<.001) and a mean effect size 
of .29 (95%+/- CI: .21, .38) suggested a moderate positive relationship existed between the 
variables. The study effect sizes and confidence intervals are available in figure 2 above. 
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In regards to publication bias, the fail-safe N suggested that 519 studies with 0 effect sizes would 
need to exist to dissolve this significant effect and Kendall’s Tau also suggested little evidence for 
publication bias (𝜏(N=17)=.15 p=.409). The funnel plot is available in figure 3 below. 
 
[Insert figure 3 here] 
The relationship between metacognition and functional outcome 
 
[Insert figure 4 here]  
Table three contains the individual study information for those included in the meta-analysis of 
the relationship between metacognition and functional outcome. Metacognition was measured 
through a variety of methods in the papers included. Three of the studies included the 
Metacognition Assessment Scale (MAS) as their measurement of metacognitive processing, two 
the WCST-meta paradigm, one the Beck Cognitive Insight Scale and a final paper used a factor 
comprised of the MAS and BCIS scales.  
In relation to functional outcome, three studies employed the Global Assessment of Functioning 
(GAF) measure, two more the Quality of Life (QoL) interpersonal relations measure which is a 
semi-structured interview assessing the frequency of social contacts , one study used the UPSA 
performance-based functional capacity measure and one used the Specific Levels of Functioning 
(SLOF) interpersonal functioning subscale, an interviewer-rated assessment of functioning. 
 
[Insert table 2 here] 
 
The seven studies included for the meta-analysis had an effect size range of 0.17 to 0.57 and the 
total sample size was 645. The Q (Q= 65.09, df=6, p>.05) and I2 (I2= 0) statistic suggest 
homogeneity was present across study domains indicating that there was not a significant 
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difference in effect sizes found across studies. The mean effect size across studies was .24, the 
confidence intervals (CI.95) were .17 (lower) to .31 (upper) and a highly significant associated Z 
score between studies was also observed (z= 6.11, p=<.001). The forest plot with individual study 
and mean effect size and confidence intervals is available in figure 5 below. This infers a small-
moderate positive effect size (Cohen, 1992) between metacognitive ability and function such that 
increased metacognitive ability is associated with higher function.  
[Insert figure 5 here] 
An inspection of the fail-safe N value indicates that there would need to be 95 unpublished 
studies with 0 effect sizes to ameliorate the significant effect found and an inspection of 
Kendall’s Tau suggests little publication bias (𝜏(N=7)=.52 p=..099). Despite a small number of 
studies being present, the funnel plot provides corollary evidence for no significant publication 
bias being present (see figure 6 below). 
[Insert figure 6 here] 
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Sub-domain analysis 
 
[Insert table 3 here] 
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Discussion 
The results indicate that dysfunctional metacognitive processing is associated with impoverished 
cognitive processing as demonstrated in cross-sectional studies gathered from the last 15 years. 
The individual meta-analysis results indicate a moderate effect size for neurocognition on 
metacognitive processing. The second analysis confirms that there is a small-moderate relationship 
between metacognition and functional outcome across studies. 
The relationship between neurocognition and metacognition 
Firstly, an overall significant relationship was found between combined measures of 
neurocognition and metacognition and a small-to-moderate mean effect size was reported. In 
relation to individual cognitive domains and metacognition, executive function was the most 
frequently investigated domain. In terms of metacognitive knowledge, conceptually the 
relationship makes sense. In order to produce and form accurate beliefs about mental states, a 
series of cognitive abilities (recall, emotional recognition) are required, however in order to do this 
successfully, one must be able to monitor, inhibit irrelevant information, and switch between belief 
sets to judge and reflect. Likewise, in relation to the BCIS, executive function in addition to 
memory may be required in order to hold contextual information online to assess judgements and 
notice distortions or erroneous outputs/conclusions. The vocabulary subscale of the WAIS was 
the second most employed measure of neurocognition in the present study. In order to recall and 
describe the synthesis of internal and external mental states vocabulary is required to compose the 
narrative. The vocabulary subset of the WAIS is also employed as a proxy measure of pre-morbid 
IQ function. This suggests that IQ prior to becoming unwell may also underpin successful 
metacognitive processing; those that retain their premorbid IQ may be better able to inspect 
cognitive states and put them in perspective. Working Memory has certainly been associated with 
the MAS as, in order to reflect on mental states, these mental states need to be held in working 
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memory in the first instance. These relationships were all found in the smaller, cognitive 
subdomain meta-analyses (table 3). 
The relationship between metacognition and functional outcome 
The results of the second meta-analysis indicate that metacognitive processing has a small to 
moderate sized effect on functional outcome in schizophrenia. Furthermore, these individual 
effects observed in preliminary studies are consistently found across designs. This relationship was 
found across clinician-rated measures of outcome and capacity based measures however it must 
be noted that only one paper in the review addressed the latter. Put simply, better metacognitive 
abilities relate to better functional outcome in those with a diagnosis of schizophrenia as 
demonstrated across a larger participant pool in the present study. Having the ability to integrate 
and reflect on one’s cognition, and use this skill to manage social interactions, may be critical to 
managing relationships and occupational recovery. These metacognitive abilities may be more 
pertinent skills to successful community integration than cognitive ability alone. Interestingly, 
O’Connor and colleagues (O’Connor et al., 2013) found that once negative symptoms, ethnicity 
and gender were controlled for in analysis, this relationship between metacognition and outcome 
was not significant. This may be reflective of the measure used (cognitive insight) having a more 
pronounced impact on function longer term whereas symptoms are a better predictor of 
functioning in the short term.  
Despite the few studies included in this exploratory meta-analysis, there is little indication of 
publication bias and a large number of unpublished studies would need to be present in order to 
ameliorate the observed relationships found in the analyses. 
Limitations 
As with all meta-analyses, there were some systemic problems in the data included in analysis. 
Firstly, due to different study designs, the analysis had to find a balance between conceptual 
integrity when combining variables, and running analysis on a meaningful amount of data. The 
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neurocognition and metacognition analysis was conducted on 17 studies however the measure of 
neurocognition included varied between studies. Whilst there is preliminary evidence to suggest 
that the MAS and BCIS are homogenous in measurement (Lysaker et al.,, 2013), more work needs 
to be completed in the area to improve confidence in this conceptual alignment.  
The lack of consistently employed, standardised measures makes cross-study comparisons difficult 
(Green et al., 2008). There has been a consensus in schizophrenia research to address this problem 
and great steps have been made in introducing the MATRICS neurocognitive battery 
(Nuechterlein et al., 2012) however the studies reported in this review have yet to benefit from 
this initiative. Likewise, even studies employing the MAS tended to report different subscales, and 
infrequently total scores, which prevents an assessment of the influence of differing cognitive 
domains on different aspects of metacognitive function. 
A final problem was found in the sample descriptions; whilst some studies reported that the sample 
recruited was from a higher-functioning cohort, some of the studies employed different diagnostic 
entry criteria and some gave little description other than ‘persons with schizophrenia’. Thus it is 
difficult to claim with certainty that similar clinical profiles are being compared. Likewise, only one 
of the studies was completed in FEP (Lepage et al., 2008); whilst work on both neurocognition 
(Mesholam-Gately et al., 2009) and metacognition (Macbeth et al., 2014; Davies, Greenwood & 
Fowler, 2016) have been investigated in FEP, the relationship between neurocognition, 
metacognition and functional outcome specifically has not. Lepage and colleagues (2008) found 
no significant relationship between the BCIS and memory however whether this is symptomatic 
of the relationship having not manifest in early-onset samples or whether this was due to measure 
selection is hard to elucidate due to the dearth in studies. 
One of the main problems identified in the literature is capturing the nature of functioning in 
schizophrenia. In four of the studies, functioning was assessed by self-report or a clinician-rated 
measure which may be victim to confounding variables such as clinical insight. Performance-based 
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measures are being suggested as a better measurement of function (Depp et al., 2012) however 
only one study in the present review assessed functional outcome this way (Lysaker et al., 2011a).  
Whilst the inspection of publication bias did not highlight any significant ‘file-draw’ problems, 
studies did not always report all of the gathered data across constructs. The full reporting of 
different aspects of outcome and refraining from the use of composite aspects of function would 
make comparisons more meaningful. Symptom measurement would prove important to include 
in analysis across studies as well but studies varied in both the measurement and data reported for 
this variable. 
Future directions 
One of the main suggestions made in the studies included in the present review relates to future 
studies needing to replicate findings in different cohorts such as first-episode. A plethora of studies 
list sample selection as a potential problem, with schizophrenia samples largely comprised of 
middle-aged, chronic presentation, males. The relationships found may in part be due to differing 
treatment exposures, neuroleptic medication therefore replication must be made in more diverse 
samples such as those at first-episode, those refusing treatment and female participants. For 
example, neuroleptic medication has been demonstrated to impair processing speed in 
schizophrenia (Veselinovic et al., 2013) and processing speed has been linked to both working 
memory and executive function. Whether the deficits observed in these domains is due to cognitive 
impairment or impairment due to medication exposure would be valuable to investigate. The effect 
of the aforementioned potential confounding variables may be reduced with recruitment in early-
onset samples. Future researchers need to employ multiple measures of both neurocognition and 
metacognition across longitudinal designs to really elucidate the relationship between these 
concepts. There also appears to be a dearth in research investigating environmental factors and 
their relationship to metacognition in schizophrenia, future work may benefit from considering 
the role of sociodemographic factors in analysis. 
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Conclusions 
In conclusion, the present meta-analysis found small-to-moderate effects between neurocognition 
and metacognition and small-to-moderate relationships between metacognition and functional 
outcome. The present review bolsters the theory that neurocognition is a pillar stone upon which 
metacognition is built, and this relationship is found across studies consistently. The present review 
extends this for the first time to demonstrate that metacognition is related to functional outcome 
in schizophrenia across studies. These findings enable a better understanding of the mechanics 
driving individual recovery in function with schizophrenia and may be used to elucidate further 
the known relationship between neurocognition and functional outcome. Aspects of 
metacognition have the scope to contribute to the ability for an individual to return to work, 
maintain social relationships, live independently and manage symptoms in the community however 
this relationship needs further exploration and refinement. Questions remain about the manner in 
which negative symptoms (also implicated in functional outcome) interact with metacognition and 
functional outcome, and how these relationships change over time and through recovery. 
Potentially symptoms may be more predictive of cross-sectional functioning39 however longer-
term, metacognition may be of importance once symptoms have been addressed. By 
understanding the relationship further, cognitive remediation and metacognitive behavioural 
therapy can be focused and refined to give those with a schizophrenia diagnosis the raw skills to 
regain their functional abilities. 
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Tables 
 
Table 1: Search results for neurocognition and metacognition 
Study N Diagnosis Mean age (SD) % 
female 
Design Cognitive domain(s) Metacognitive 
domain(s) 
Lysaker et 
al., (2005) 
61 DSM-IV 
schizophrenia/schizoaffective 
47.7(6.8) 0 Cross-
sectional 
WAIS III (V, DS) WMS III (VR) 
HVLT, WCST (cat) 
MAS (Understanding 
one’s own mind, 
understanding other’s 
mind, mastery) 
Lysaker et 
al., (2007) 
69 DSM-IV 
schizophrenia/schizoaffective 
46.68(10.11) 11.59 Cross-
sectional 
WAIS III (A, V, BD, DS) WMS III 
(VR, LM), WCST (cat, per), 
BLERT (+ve, -ve emotions) 
MAS (Understanding 
one’s own mind, 
decentration) 
Lepage et 
a., (2008) 
51 FEP 23.2 (3.8) 29 Cross-
sectional 
WAIS III (DS, BD) WMS III (VR, 
LM, SS), TMT (A, B), ToL, d2, 
FFToSI, Hinting Test 
BCIS (SR, SC, CI) 
Lysaker et 
al., (2008) 
49 DSM-IV 
schizophrenia/schizoaffective 
49.63(5.71) 0 Cross-
sectional 
DKEFS (DF VF WS ST WC 20Q) MAS (Understanding 
one’s own mind, 
understanding other’s 
mind, mastery), BCIS 
(CI) 
Orfei et al., 
(2010) 
60 DSM-IV schizophrenia 38(11.1) 38 Cross-
sectional 
Mental Deterioration Battery (RIR 
RDR CD CDL Pm 47 PVF SCT 
IVM MWCST) ROPDR, CROP, 
CF 
BCIS (SR, SC, CI) 
Lysaker et 
al., (2010b) 
37 DSM-IV 
schizophrenia/schizoaffective 
46.94 (10.77) 5.41 Cross-
sectional 
WCST (pers) HVLT MAS (Understanding 
one’s own mind, 
understanding other’s 
mind, mastery) 
Lysaker et 
al., 2010a) 
102 DSM-IV 
schizophrenia/schizoaffective 
46.54(9.37) 15 Cross-
sectional 
WAIS III (V DS), WMS III (VR), 
WCST (cat) HVLT (composite 
score used in analysis) 
MAS (mastery) 
Nicolo`et 
al., (2012) 
45 DSM-IV 
schizophrenia/schizoaffective 
38.18(11.2) 40 Cross-
sectional 
WAIS III (V DS), WMS III (VR), 
WCST (cat), RIR 
MAS (Understanding 
one’s own mind, 
understanding other’s 
mind, mastery) 
Hamm et 
al., (2012) 
49 DSM-IV 
schizophrenia/schizoaffective 
50.37(7.54) 10.2 Longitudinal WCST (cat), BLERT (total) MAS (total) 
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Study N Diagnosis Mean age (SD) % 
female 
Design Cognitive domain(s) Metacognitive 
domain(s) 
Bruno et al., 
(2012) 
28 DSM-IV schizophrenia  Delusional 
35.07(6.86) 
Non-delusional 
33.5(9.9) 
32.14 Cross-
sectional 
fNART (V P IQ), WCST (cat rules 
pers SL) 
BCIS (SR SC CI), 
WCST-meta (Q A FC G 
M C) 
Giusti et al., 
(2013) 
20 Schizophrenia diagnosis 36.2(9.8) 30 Cross-
sectional 
RCPM, RIR, RDR, WCFST, SST, 
Eyes (Composite score used in 
analysis) 
BCIS (SR SC CI) 
Lysaker et 
al., (2013) 
95 DSM-IV 
schizophrenia/schizoaffective 
49.36(8.7) 13.68 Cross-
sectional 
WAIS III (V), WCST (cat), 
BMERT (total), Eyes, Hinting test 
MAS (total), BCIS (CI) 
(metacognitive factor 
score used in 
analysis) 
Abu-Akel & 
Bo (2013) 
42 ICD-10 schizophrenia 41.55(8.3) 50 Cross-
sectional 
WAIS III (V) MAS (Understanding 
one’s own mind, 
understanding other’s 
mind, total) 
Minor & 
Lysaker 
(2014) 
68 DSM-IV 
schizophrenia/schizoaffective 
50.5(10.38) 35.06 Cross-
sectional 
WAIS III (LNS) WMS III (SS), 
BACS (DS), HVLT, BVMT, CPT, 
TMT (A), CF, Neuropsychological 
assessment Battery mazes, 
MSCEIT (composite score 
used in analysis) 
MAS (total) 
 
Tas et al., 
(2014) 
30 DSM-IV schizophrenia 34.43(8.56) 43.3 Cross-
sectional 
WMS (MQ), WCST (cat pers) MAS (Understanding 
one’s own mind, 
understanding other’s 
mind, decentration, 
mastery) 
Abu-Akel et 
al., (2015) 
79 ICD-10 schizophrenia 36.86(10.37) 64 Cross-
sectional 
WAIS III (V) MAS (Understanding 
one’s own mind, 
understanding other’s 
mind, mastery, total) 
Luther et 
al., (2016) 
175 DSM-IV 
schizophrenia/schizoaffective 
48.67(9.9) 13 Cross-
sectional 
WCST (cat), BLERT (total) MAS (total) 
Key: WAIS A=Arithmatic V=Vocabulary BD=Block Design DS=Digit symbolLNS=Letter-Number Sequencing; WMS VR=Visual Reproduction LM=Logical Memory SS=Spatial Span MQ=Memory 
Quotient; TMT=Trailmaking Task; d2= d2 Test of Attention; BACS DS=Digit Sequencing subtest; BVMT=Brief Visuospatial MemoryHVLT=Hopkins Verbal Learning Test; BLERT +ve=positive 
emotions –ve=negative emotions; FFToSI=Four Factor Tests of Social Intelligence; WCST cat=correct categories achieved rules=rules achieved per=perserveration responses ST=Set Loss; 
CF=Category Fluency test; CPT=Continuous Performance Test; DKEFS DF=Design Fluency switching VF=Verbal Fluency switching WS=colour Word Switching ST=Sorting Task WC=Word Context 
20Q= 20 questions; Mental Deterioration Battery RIR=Rey's 15-word Immediate Recall RDR=Rey's 15-word Delayed Recall CD=Copy Drawings CDL=Copy Drawings with Landmarks PM 
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47=Raven's Progressive Matrices' 47 PVF=Phonological Verbal Fluency SCT=Sentence Construction test IVM=Immediate Verbal Memory MWCST=Modified Wisconsin Card Sorting test; 
ROPDR=Delayed Recall of Rey–Osterrieth picture; CROP=Copy of Rey–Osterrieth picture; CF=Category Fluency Test; RCPM=Raven’s Coloured Progressive Matrices; WCFST=Weigl’s Colour Form 
Sorting Test; SST=Strange Stories Test; Eyes=Reading the Mind in the Eyes Test; MSCEIT=Mayer-Salovey-Caruso Emotional Intelligence Test 
MAS=Metacognitive Assessment Scale; BCIS SR=Self-reflectivity SC=Self-certainty CI=composite index; WCST-meta Q= Quantity A=Accuracy score FC=Free Choice improvement G=Global 
monitoring M=Monitoring resolution C=Control sensitivity. Variables inlcuded in meta-analysis indicated in bold font. 
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Table 2 Systematic review results table: Metacognition and functional outcome 
Study N Diagnosis Mean 
Age 
(SD) 
% 
female 
Design Metacognition 
measure 
Outcome 
measure 
Gould et 
al., (2015) 
214 SCID DSM-IV criteria 
schizophrenia/schizoaffective 
disorder 
40 
(12.4) 
35 Cross-
sectional 
Wisconsin 
Card Sorting 
Task-meta 
(accuracy) 
Specific 
Levels of 
Functioning 
(SLOF) scale 
(interpersonal 
function) 
Abu-Akel & 
Bo, (2013) 
42 ICD-10 diagnostic criteria for 
schizo- phrenia 
41.55 
(8.3) 
50 Cross-
sectional 
Metacognition 
Assessment 
Scale (total) 
Global 
Assessment 
of Functioning 
(total) 
O’Connor 
et al., 
(2013) 
127 DSM-IV criteria 
schizophrenia or related 
disorder, or affective disorder 
with psychotic features 
29.75 
(8.95) 
31  
Cross-
sectional 
Beck 
Cognitive 
Insight Scale 
Global 
Assessment 
of Functioning 
(psychosocial) 
Lysaker, 
Gumley et 
al., (2013) 
95 DSM-IV criteria for 
schizophrenia 
49.36 
(8.7) 
13.68 Cross-
sectional 
Metacognitive 
Awareness 
factor 
Quality of Life 
Scale 
(Interpersonal 
relations) 
Lysaker, 
McCormick 
et al., 
(2011a) 
45 DSM-IV criteria for 
schizophrenia 
48.50 
(8.62) 
10 Longitudinal Metacognition 
Assessment 
Scale 
(mastery) 
Functional 
capacity-
UPSA (total) 
Lysaker et 
al., (2010a) 
102 DSM-IV criteria for 
schizophrenia 
46.54 
(9.37) 
15  Metacognition 
Assessment 
Scale 
(mastery) 
Quality of Life 
(interpersonal 
relations) 
Stratta et 
al., (2009) 
20 DSM-IV criteria for 
schizophrenia 
35.2 
(10.02) 
15  Wisconsin 
Card Sorting 
Task-meta 
(accuracy) 
Global 
Assessment 
of Functioning 
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Table 3: Individual cognitive domain analyses 
   Heterogeneity 
Test 
  
Variable Mean 
effect 
size 
+/-95% 
Confidence 
Intervals 
Q df p Number of 
Studies 
Total 
Sample 
Executive 
Functioning 
.192 .078- .302 11.43 11 .408 12 718 
Verbal IQ .339 .212- .454 8.24 7 .312 8 456 
Memory .302 .178- .416 6.09 6 .413 7 343 
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Figures: 
 
 
Figure 1 Neurocognition and metacognition search result consort diagram 
 
Figure 2 Cognition and metacognition forest plot 
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Figure 3 Funnel plot for the relationship between cognition and metacognition 
Review article: Neurocognition, metacognition and function 
 
 
Figure 4: Search result consort diagram for metacognition and functional outcome 
 
Figure 5 Metacognition and functional outcome forest plot (effect sizes and confidence intervals) 
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Figure 6: Funnel plot for metacognition and functional outcome 
 
